Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Augustyn, Alexander"'
Autor:
Augustyn A; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Adams DL; Creatv MicroTech Inc, Monmouth Junction, NJ., He J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Qiao Y; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Verma V; Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA., Liao Z; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Tang CM; Creatv MicroTech Inc, Rockville, MD., Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Tsao AS; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Lin SH; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: shlin@mdanderson.org.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2021 May; Vol. 22 (3), pp. e451-e465. Date of Electronic Publication: 2020 Jun 20.
Autor:
Augustyn A; Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, and., Borromeo M; Departments of Neuroscience., Wang T; Simmons Comprehensive Cancer Center, and Clinical Sciences., Fujimoto J; Departments of Thoracic/Head and Neck Medical Oncology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030;, Shao C; Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, and., Dospoy PD; Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, and., Lee V; Hamon Center for Therapeutic Oncology Research., Tan C; Hamon Center for Therapeutic Oncology Research., Sullivan JP; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; and., Larsen JE; Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4006, Australia., Girard L; Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, and Pharmacology., Behrens C; Departments of Thoracic/Head and Neck Medical Oncology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030;, Wistuba II; Departments of Thoracic/Head and Neck Medical Oncology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030;, Xie Y; Simmons Comprehensive Cancer Center, and Clinical Sciences., Cobb MH; Simmons Comprehensive Cancer Center, and Pharmacology., Gazdar AF; Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, and Pathology, and., Johnson JE; Departments of Neuroscience, Pharmacology., Minna JD; Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, and Pharmacology, Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75235; john.minna@utsouthwestern.edu.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2014 Oct 14; Vol. 111 (41), pp. 14788-93. Date of Electronic Publication: 2014 Sep 29.
Autor:
Shao C; Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center., Sullivan JP; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts;, Girard L; Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, Pharmacology, and., Augustyn A; Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center., Yenerall P; Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center., Rodriguez-Canales J; Department of Translational Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston; Departments of., Liu H; Department of Translational Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston; Departments of., Behrens C; Department of Translational Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston; Departments of., Shay JW; Cell Biology., Wistuba II; Department of Translational Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston; Departments of., Minna JD; Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, Pharmacology, and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas john.minna@utsouthwestern.edu.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2014 Aug 01; Vol. 20 (15), pp. 4154-66. Date of Electronic Publication: 2014 Jun 06.
Autor:
Shao, Chunli, Sullivan, James P., Girard, Luc, Augustyn, Alexander, Yenerall, Paul, Rodriguez, Jaime, Liu, Hui, Behrens, Carmen, Shay, Jerry W., Wistuba, Ignacio I., Minna, John D.
Lung cancer stem cells (CSC) with elevated aldehyde dehydrogenase (ALDH) activity are self-renewing, clonogenic, and tumorigenic. The purpose of our study is to elucidate the mechanisms by which lung CSCs are regulated.A genome-wide gene expression a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fac6aa0586e20900a24b281aeba129cd
https://europepmc.org/articles/PMC4438754/
https://europepmc.org/articles/PMC4438754/